Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
TCR-based bispecific therapeutics for cancer and autoimmune disease
T-Therapeutics is a biotechnology company developing T cell receptor-based therapeutics for cancer and autoimmune disease. Using a humanised TCR mouse platform to generate high-affinity, antigen-specific human T cell receptors, the company engineers bispecific molecules that redirect a patient's own T cells to…
AI-powered drug discovery and repurposing for rare diseases
Healx is a clinical-stage biotech applying AI to drug discovery and repurposing for rare diseases. Its platform analyses drug and disease data at scale to identify novel treatment relationships, enabling multiple discovery programmes to run in parallel. The lead programme targeting neurofibromatosis type 1 entered…
Quantum simulation and AI platform for enzyme-targeted drug discovery
Kuano is a computational drug discovery company combining quantum simulation with artificial intelligence to design inhibitors against enzyme targets. The platform models transition states during enzyme reactions, quantum mechanical events inaccessible to classical structure-based methods generating a Quantum…
Specialist life science research product distributor for UK and Ireland
Cambridge Bioscience is a specialist distributor of life science research products and services, supplying academic, pharmaceutical and biotechnology organisations across the UK and Ireland. The company curates a portfolio of reagents, antibodies, biochemicals, instruments and genomics tools from global manufacturing…
Programmable iPSC cell therapies for cancer and autoimmunity
Xap Therapeutics is a Cambridge-based biotechnology company developing a synthetic biology platform for next-generation cell therapeutics. The company applies CRISPR technology to engineer induced pluripotent stem cells (iPSCs) into a universal "chassis" cell that can be functionalised with engineered receptors and…
High-purity animal-free growth factors and cytokines for cell culture
Qkine is a biotechnology company manufacturing recombinant growth factors and cytokines for stem cell, organoid and regenerative medicine research. Proteins are produced in E. coli using animal-free methods, with engineered variants available offering improved thermostability and extended bioactivity in culture. The…
UK and Ireland distributor of specialist analytical and life science instruments
Analytik is a scientific instrumentation distributor supplying specialist equipment to research, academic, and industrial organisations across the UK and Ireland. The company holds exclusive or preferred distribution agreements with a portfolio of international technology manufacturers, covering particle…
Microbial CRO for natural product discovery and fermentation scale-up
Isomerase is a company providing contract research and development services centred on microbial synthetic biology, with expertise spanning natural product discovery, enzyme engineering, strain bioengineering, and fermentation process development. It serves clients across pharma, biotech, agritech, food and consumer…
Oral delivery platform for biologics targeting inflammatory diseases
Intract Pharma is a biotechnology company developing proprietary formulation platforms for the oral delivery of complex biologics including monoclonal antibodies and proteins. The technology enables precision delivery to the colon for local and systemic immunomodulation, targeting gastrointestinal and systemic…
Light-controlled droplet microfluidics for single-cell functional analysis
Lightcast Discovery is a life science tools company developing a droplet-based system for single-cell functional analysis. Using light to precisely control picolitre-scale droplets, the platform enables parallel interrogation of tens of thousands of individual cells across a range of functional assays, including…
Ultra-fast PCR point-of-care diagnostics from swab to result
LEX Diagnostics is a molecular diagnostics company developing rapid point-of-care PCR testing through its proprietary thermal cycling platform. Its system delivers quantitative PCR results directly from a dry swab in six to ten minutes with no sample preparation, targeting respiratory infections including influenza…
Global population genomics platform for drug target discovery and clinical trials
Omnigen Biodata is a biotechnology company operating the Discover Me platform, a global population health and genomics research programme integrating health and genetic data from participants across multiple countries. The platform generates large-scale biodata resources used by pharmaceutical partners to identify…
Proprietary formulation platform enhancing diabetes and cardiometabolic therapies
Arecor Therapeutics is a biopharmaceutical company developing enhanced formulations of existing therapeutic products for diabetes and cardiometabolic diseases. Its proprietary formulation technology improves stability, concentration and delivery profiles for biologics and peptides, supporting both in-house programmes…
Ocean-microbe fermentation platform for sustainable biosurfactants in personal care
BravelyCultured is a UK-based biotechnology company developing sustainable, biodegradable chemicals using ocean-based microorganisms and fermentation. The company's current focus is biosurfactants for personal and home care products, offering a skin-friendly, cost-effective alternative to synthetic surfactants.…
Non-invasive small molecule eye drops for retinal vascular disease
Foventa is a biopharmaceutical company developing non-invasive, small molecule therapeutics for retinal vascular diseases that can cause vision loss. Its lead candidate targets VEGF splicing, a mechanism underlying abnormal blood vessel growth in conditions including diabetic retinopathy and diabetic macular oedema.…
Genomics-led breeding of climate-resilient food crops
Viridian Seeds is an agricultural biotechnology company developing climate-resilient crop varieties using genomics-assisted trait discovery and plant breeding. Its research focuses on legumes, including chickpeas, lentils and soybeans, and improved tomatoes for sustainable food production. The company reports an…
Rare disease partnering platform connecting patient groups with drug developers
Aspire Biosciences is a Cambridge-based company accelerating treatment development for rare and unaddressed diseases through its Systematic Serendipity methodology. The company facilitates structured partnerships between rare disease patient organisations and pharmaceutical and biotechnology companies through…
Ultra-high-throughput biologics discovery platform powered by generative AI
Sortera Bio is a biotechnology company developing an AI-powered platform for the discovery and engineering of biological therapeutics. The Deep Screening platform generates sequence and functional data across hundreds of millions of biologics in a single experiment, producing large-scale training datasets for…
Immunotherapies targeting blood cancer precursor conditions before onset
Athernal Bio is a Cambridge-based biotechnology company developing targeted immunotherapies for high-risk clonal haematopoiesis, a widespread blood stem cell mutation condition that significantly increases the risk of acute myeloid leukaemia and other haematological cancers. The company's pipeline comprises three…
AI and multi-omics platform for cardiovascular drug target discovery
CardiaTec Biosciences is a Cambridge-based biotech applying artificial intelligence to large-scale multi-omic data to identify novel drug targets for cardiovascular diseases. Its platform integrates data across genomic, epigenomic, transcriptomic, proteomic and metabolomic layers to map disease mechanisms and uncover…